Letter: Improving the bioavailability of digoxin.
作者信息
Binnion P F, Klopp R W
出版信息
Lancet. 1975 Jun 28;1(7922):1422-3. doi: 10.1016/s0140-6736(75)92631-8.
PMID:49581
Abstract
摘要
相似文献
1
Letter: Improving the bioavailability of digoxin.信件：提高地高辛的生物利用度。
Lancet. 1975 Jun 28;1(7922):1422-3. doi: 10.1016/s0140-6736(75)92631-8.
2
Bioavailability of digoxin in a new soluble pharmaceutical formulation in capsules.地高辛在一种新型胶囊可溶性药物制剂中的生物利用度。
J Pharm Sci. 1977 Feb;66(2):267-9. doi: 10.1002/jps.2600660233.
3
Pharmacokinetics and bioavailability of digoxin capsules, solution and tablets after single and multiple doses.地高辛胶囊、溶液剂和片剂单剂量及多剂量给药后的药代动力学和生物利用度
Am J Cardiol. 1978 Jul;42(1):129-36. doi: 10.1016/0002-9149(78)90997-9.
4
Bioavailability and related heart function index of digoxin capsules and tablets in cardiac patients.
J Pharm Sci. 1979 Jan;68(1):104-6. doi: 10.1002/jps.2600680135.
5
A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.口服地高辛胶囊、片剂和溶液与静脉注射地高辛的生物利用度比较。
J Clin Pharmacol. 1976 Oct;16(10 Pt 1):461-7.
6
[Biologic availability of digoxin in soft gelatin capsules and in tablets].
Boll Soc Ital Biol Sper. 1974 Oct 15;50(19):1612-4.
7
Equivalent bioavailability from digoxin elixir and rapid-dissolution tablets.
JAMA. 1974 Sep 23;229(13):1774-6.
8
Bioavailability of digoxin in capsules.
Int J Clin Pharmacol Biopharm. 1978 Jul;16(7):320-2.
9
Letter: Discrepancy between solution and bioavailability of digoxin tablets.信函：地高辛片的溶出度与生物利用度之间的差异
Lancet. 1975 Feb 8;1(7902):343. doi: 10.1016/s0140-6736(75)91261-1.
10
The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.地高辛片与地高辛胶丸给药方案的可比性。
Br J Clin Pharmacol. 1977 Apr;4(2):209-11. doi: 10.1111/j.1365-2125.1977.tb00696.x.
Zotero 插件